COVID-19, a self-limiting disease - A case report of a severe COVID-19 pneumonia patient with multiple comorbidities successfully treated without antivirals

Vania Azalia Gunawan, Erwin Astha Triyono

Research output: Contribution to journalArticlepeer-review

Abstract

COVID-19 pneumonia is a communi cabledisease with no definite therapy. Ther apeuticre commendations are still evolving based on ongoing studies and clinical trials. Patients with comorbidities, such as obesity and diabetes, are at risk for developing more severe diseases with higher mortality rates. A number of antivirals, such as oseltamivir, favipiravir, and remdesivir, have been proposed as a treatment for COVID-19, especially in severe diseases. However, the World Health Organization (WHO) initially does not recommend any antiviral therapy. Appropriate management, including oxygen, anti-inflammation, and anti-coagulant, is recommended as the main guideline to provide appropriate treatment with minimal side effects. This case report aims to highlight a severe COVID-19 pneumonia patient with multiple comorbidities who was successfully treated without any antiviral.

Original languageEnglish
Pages (from-to)182-186
Number of pages5
JournalGaceta Medica de Caracas
Volume132
Issue number1
DOIs
Publication statusPublished - Jan 2024

Keywords

  • antiviral
  • communicable disease
  • COVID-19
  • diabetes
  • inflammation
  • obesity

Fingerprint

Dive into the research topics of 'COVID-19, a self-limiting disease - A case report of a severe COVID-19 pneumonia patient with multiple comorbidities successfully treated without antivirals'. Together they form a unique fingerprint.

Cite this